International journal of cancer
Reply to: Comments on "Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)".
Javier Molina-Cerrillo, Giandomenico Roviello, Ondrej Fiala, Tarek Taha, Sebastiano Buti, Mimma Rizzo, Francesco Massari, Fernando Sabino Marques Monteiro, Matteo Santoni
Published: 202510.1002/ijc.70289
No abstract available for this study.